mitomycin has been researched along with Corneal Endothelial Cell Damage in 10 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate changes in corneal endothelial cell counts after pterygium surgery with application of mitomycin C (MMC) either on the perilimbal sclera or in the subconjunctival space." | 9.15 | Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location. ( Behrouz, MJ; Hashemian, H; Izadi, A; Kheirkhah, A; Kiarudi, MY; Nazari, R, 2011) |
| "The aim of this study was to evaluate the anterior corneal surface regularity and light scattering before and after Descemet membrane endothelial keratoplasty (DMEK) with epithelial debridement and application of mitomycin C in Fuchs dystrophy-affected eyes with preoperative subepithelial fibrosis or anterior basement membrane dystrophy." | 7.80 | Descemet membrane endothelial keratoplasty combined with epithelial debridement and mitomycin-C application for fuchs dystrophy with preoperative subepithelial fibrosis or anterior basement membrane dystrophy. ( Chaurasia, S; McKee, Y; Price, FW; Price, MO, 2014) |
| "To evaluate changes in corneal endothelial cell counts after pterygium surgery with application of mitomycin C (MMC) either on the perilimbal sclera or in the subconjunctival space." | 5.15 | Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location. ( Behrouz, MJ; Hashemian, H; Izadi, A; Kheirkhah, A; Kiarudi, MY; Nazari, R, 2011) |
| "8% of eyes (n=10) required at least 1 mitomycin C (MMC)-enhanced needling revision to maintain their target intraocular pressure." | 3.96 | Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results. ( Bravetti, GE; Gillmann, K; Mansouri, K; Mermoud, A; Rao, HL, 2020) |
| "The aim of this study was to evaluate the anterior corneal surface regularity and light scattering before and after Descemet membrane endothelial keratoplasty (DMEK) with epithelial debridement and application of mitomycin C in Fuchs dystrophy-affected eyes with preoperative subepithelial fibrosis or anterior basement membrane dystrophy." | 3.80 | Descemet membrane endothelial keratoplasty combined with epithelial debridement and mitomycin-C application for fuchs dystrophy with preoperative subepithelial fibrosis or anterior basement membrane dystrophy. ( Chaurasia, S; McKee, Y; Price, FW; Price, MO, 2014) |
| "Patients with primary open angle glaucoma, not controlled with medication, were selected from the outpatient department." | 2.87 | Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C. ( Ahmed, N; Amjad, A; Shaheer, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gillmann, K | 1 |
| Bravetti, GE | 1 |
| Rao, HL | 1 |
| Mermoud, A | 1 |
| Mansouri, K | 1 |
| Shaheer, M | 1 |
| Amjad, A | 1 |
| Ahmed, N | 1 |
| Higashide, T | 1 |
| Nishino, T | 1 |
| Sakaguchi, K | 1 |
| Yamada, Y | 1 |
| Sugiyama, K | 1 |
| Hofmeister, EM | 1 |
| Bishop, FM | 1 |
| Kaupp, SE | 1 |
| Schallhorn, SC | 1 |
| Ryoo, NK | 1 |
| Kim, MK | 1 |
| Wee, WR | 1 |
| Chaurasia, S | 1 |
| Price, MO | 1 |
| McKee, Y | 1 |
| Price, FW | 1 |
| Santhiago, MR | 1 |
| Kheirkhah, A | 1 |
| Izadi, A | 1 |
| Kiarudi, MY | 1 |
| Nazari, R | 1 |
| Hashemian, H | 1 |
| Behrouz, MJ | 1 |
| Gambato, C | 1 |
| Miotto, S | 1 |
| Cortese, M | 1 |
| Ghirlando, A | 1 |
| Lazzarini, D | 1 |
| Midena, E | 1 |
| Zarnowski, T | 1 |
| Kosior-Jarecka, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-enrollment, Prospective Study of Endothelial Keratoplasty Outcomes[NCT00800111] | 2,593 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| The Comparison of Endothelial Cell Count in Pterygium Surgery Relating to the Timing of MMC Application.[NCT02641132] | Phase 4 | 62 participants (Anticipated) | Interventional | 2015-09-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for mitomycin and Corneal Endothelial Cell Damage
| Article | Year |
|---|---|
Comparison of Mean Corneal Endothelial Cell Loss after Trabeculectomy with and without Mitomycin C.
Topics: Aged; Antimetabolites; Corneal Endothelial Cell Loss; Endothelium, Corneal; Female; Glaucoma, Open-A | 2018 |
Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
Topics: Adult; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Corneal Opacity; Dose-Response | 2013 |
Effects of mitomycin C on corneal endothelial cell counts in pterygium surgery: role of application location.
Topics: Adolescent; Adult; Alkylating Agents; Amnion; Cell Count; Combined Modality Therapy; Conjunctiva; Co | 2011 |
Mitomycin C-assisted photorefractive keratectomy in high myopia: a long-term safety study.
Topics: Administration, Topical; Adult; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Endoth | 2011 |
6 other studies available for mitomycin and Corneal Endothelial Cell Damage
| Article | Year |
|---|---|
Impact of Phacoemulsification Combined with XEN Gel Stent Implantation on Corneal Endothelial Cell Density: 2-Year Results.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Endothelium, | 2020 |
Determinants of Corneal Endothelial Cell Loss After Trabeculectomy With Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Cell Count; Combined Modality Therapy; Corneal En | 2019 |
Consequences of accidental mitomycin C intraocular injection.
Topics: Alkylating Agents; Atrophy; Corneal Edema; Corneal Endothelial Cell Loss; Humans; Injections, Intrao | 2013 |
Descemet membrane endothelial keratoplasty combined with epithelial debridement and mitomycin-C application for fuchs dystrophy with preoperative subepithelial fibrosis or anterior basement membrane dystrophy.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Basement Membrane; Corneal Endothelial Cell Loss; | 2014 |
Refractive surgical problem: December consultation #1.
Topics: Adult; Alkylating Agents; Corneal Endothelial Cell Loss; Endothelium, Corneal; Epikeratophakia; Fema | 2014 |
Progression of normal tension glaucoma in Kearns-Sayre syndrome over 10 years.
Topics: Adult; Alkylating Agents; Corneal Endothelial Cell Loss; Disease Progression; Female; Follow-Up Stud | 2012 |